Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment.
Luo H, Xia X, Huang LB, An H, Cao M, Kim GD, Chen HN, Zhang WH, Shu Y, Kong X, Ren Z, Li PH, Liu Y, Tang H, Sun R, Li C, Bai B, Jia W, Liu Y, Zhang W, Yang L, Peng Y, Dai L, Hu H, Jiang Y, Hu Y, Zhu J, Jiang H, Li Z, Caulin C, Park J, Xu H. · 2022
Read Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. by Luo H, Xia X, Huang LB, An H, Cao M, Kim GD, Chen HN, Zhang WH, Shu Y, Kong X, Ren Z, Li PH, Liu Y, Tang H, Sun R, Li C, Bai B, Jia W, Liu Y, Zhang W, Yang L, Peng Y, Dai L, Hu H, Jiang Y, Hu Y, Zhu J, Jiang H, Li Z, Caulin C, Park J, Xu H. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9636408.txt.
Introduction
Luo and co-authors run a pan-cancer single-cell analysis of cancer-associated fibroblasts and their range of states. These fibroblasts dominate the tumor setting in most cancers. They shape many cancer traits, yet shared traits across cancer types were unmapped. The team profiled the setting at single-cell level to find them.
The study covered 226 samples across 10 solid cancer types. Major fibroblast types split along a growth path with three states. Each state traded signals with other cell groups in its own way. The states also tied to how well immunotherapy might work. Minor fibroblast groups came from other setting parts instead. Some arose from vessel lining cells or from macrophages. One shared group came from endothelial to mesenchymal shift. It sat near SPP1 positive macrophages and tracked with patient survival splits. An online atlas browser shares the full data.
Catalog record
| CREATOR | Luo H, Xia X, Huang LB, An H, Cao M, Kim GD, Chen HN, Zhang WH, Shu Y, Kong X, Ren Z, Li PH, Liu Y, Tang H, Sun R, Li C, Bai B, Jia W, Liu Y, Zhang W, Yang L, Peng Y, Dai L, Hu H, Jiang Y, Hu Y, Zhu J, Jiang H, Li Z, Caulin C, Park J, Xu H. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 83 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment By Han Luo, Xuyang Xia, Li-Bin Huang, Hyunsu An, Minyuan Cao, Gyeong Dae Kim, Hai-Ning Chen, Wei-Han Zhang, Yang Shu, Xiangyu Kong, Zhixiang Ren, Pei-Heng Li Published in: Nature Communications DOI: 10.1038/s41467-022-34395-2 ABSTRACT Abstract Cancer-associated fibroblasts (CAFs) are the predominant components of the tumor microenvironment (TME) and influence cancer hallmarks, but without systematic investigation on their ubiquitous characteristics across different cancer types. Here, we perform pan-cancer analysis on 226 samples across 10 solid cancer types to profile the TME at single-cell resolution, illustrating the commonalities/plasticity of heterogenous CAFs. Activation trajectory of the major CAF types is divided into three states, exhibiting distinct interactions with other cell components, and relating to prognosis of immunotherapy. Moreover, minor CAF components represent the alternative origin from other TME components (e.g., endothelia and macrophages). Particularly, the ubiquitous presentation of endothelial-to-mesenchymal transition CAF, which may interact with proximal SPP1+ tumor-associated macrophages, is implicated in endothelial-to-mesenchymal transition and survival stratifications. Our study comprehensively profiles the shared characteristics and dynamics of CAFs, and highlight their heterogeneity and plasticity across different cancer types. Browser of integrated pan-cancer single-cell information is available at https://gist-fgl.github.io/sc-caf-atlas/. Subject terms: Cancer microenvironment, Cancer genomics, Cancer genomics, Tumour heterogeneity INTRODUCTION Along with malignant cells, heterogeneous tumor microenvironment (TME) composites are important parts of tumors. They interact with malignant cells and contribute to the hallmarks of cancer1,2. Different types of nonmalignant cells are present in the TME, mainly including fibroblasts, immune cells (e.g., myeloid cells, lymphocytes, and macrophages), and endothelial cells. Previous studies have highlighted the indispensable role of the TME in the biological capabilities of cancer, such as tumor progression, treatment resistance, angiogenesis induction, and metastasis2–4. Mechanistically, the TME influences cancer cells via complicated and dynamic pathways to regulate cancer-related signaling5, involving ligand–receptor interactions (e.g., PD-L1 of cancer cells binding to PD1 of T cells), cytokine/metabolite responses, and deposition of extracellular matrix (ECM)6–10. Of all types of stromal cells, fibroblasts are the predominant component in the TME, and cancer-associated fibroblasts (CAFs) play prominent and diverse tumor-supporting roles in cancer10,11. Besides directly interacting with malignant epithelial cells, CAFs create a tumor-permissive TME, including inducing the activation of normal fibroblasts into CAFs, promoting angiogenesis with endothelial cells12, recruiting myeloid cells13, and immunosuppression of T cells14. Therefore, CAFs play a key role in sculpting the TME by interacting with other TME components7,10,11, exhibiting their potential value as a prognostic factor and therapeutic target15. On the other hand, CAFs are primarily derived from normal fibroblasts (NFs) via several cancer type-specific mechanisms, and the modulation of CAFs to the TME is diverse and vague due to their heterogeneity and plasticity7. Recent studies have specified various subtypes of CAFs7, but the definitive origin of CAFs is controversial, and the lack of generalized characterization hinders CAF-targeted therapy in clinical practice. Meanwhile, it is difficult to define small subtypes of CAFs and investigate the plasticity of CAFs with limited cell populations, thus hindering the investigation on the evolutionary trajectory of CAFs and possible switches between CAFs and other TME components during cancer development and progression. In recent years, the development of single-cell RNA sequencing (scRNA-seq) technology has provided the opportunity to investigate fluctuations in cell status and the strength of cell plasticity15–17. The characteristics of cancer cells and the TME have been profiled in multiple types of cancer, revealing the heterogeneity of cancer samples with different components at single-cell resolution and suggesting their possible involvement in the biological capabilities of cancer11. Additionally, increasing scRNA-seq-related software and strategies have been developed to improve the accuracy of bioinformatics analysis and upgrade the analytical dimensions, including batch effect correction18, cell–cell interaction evaluation19, and evolutionary trajectory20. However, recent scRNA-seq studies are still limited by the sample size, mainly due to fresh sample availability and expenditure. On the other hand, a large sample size would facilitate characterizing the complexity of cancer by excluding individual variants and by enriching the distinct components with a small cell population, particularly those shared across different cancer types. Due to the similarity of TME cells but not cancer cells among patients with different cancer types21,22, a few scRNA-seq-based pan-cancer studies have recently been conducted to integrate the increasing accessibility of scRNA-seq profiles, thus maximizing resolution and analyzing cell quantity within controlled bias, and exhibiting the ubiquitous characteristics of TME cells21–24. However, these pan-cancer studies have only focused on the characteristics of immune cells, omitting the interactions between different cell components. In this study, we combine public and inhouse scRNA-seq data to profile the TME across 10 common solid cancer types, characterizing the interconvertibility and interaction among different types of stromal cells, with a particular focus on the ubiquitous characteristics of CAFs among diverse cancer types and the plasticity of CAF subtypes. Our systematic investigation on CAFs and their subtypes across cancers at single-cell resolution highlights the possible heterogeneity and plasticity of CAFs in cancer biology. RESULTS Landscape of the TME in pan-cancer illustrated using scRNA-seq analysis To profile the TME landscape of solid cancers, we compiled a single-cell transcriptional atlas in 10 common solid cancer types (Fig. 1a), with 148 primary tumor, 53 adjacent, and 25 normal samples from 164 donors enrolled in 12 studies (Fig. 1b and Supplementary Data 1). Available independent cohorts of patients with the same cancer type (i.e., pancreatic, lung and prostate cancers) were included to establish internal validation (Fig. 1b). Additionally, scRNA-seq data of the counterpart normal tissues from public resources were included to match the selected cancer type (Fig. 1b)25. To exclude possible technology-induced bias, all scRNA-seq data were generated using the same platform (i.e., 10× Genomics) without specific sorting. After strict quality control and filtering, a total of 855,271 cells from 226 samples were included and integrated based on a batch effect correction algorithm (Supplementary Fig. S1a). Next, unsupervised clustering generated a total of 34 TME-related clusters (c1-c34, 569,759 cells), which were separated from cancerous/normal epithelial cells (Fig. 1c and d). These clusters were divided into five major cell components based on canonical markers of different cell types, including fibroblasts (c1-c8, DCN, COL1A1), lymphocytes (c9-c17, CD3D, CD3E), myeloid cells (c18-c24, CD68, CD14), endothelial cells (c25-c28, VWF, PECAM1), and plasma cells (c29-c34, IGHG1, JCHAIN) (Fig. 1c, e and Supplementary Data 2). The remaining cells were clustered as epithelial cells (EPCAM, KRT19) (Fig. 1c). No obvious bias of the TME was observed regardless of malignant state and tissue type (Supplementary Fig. S1b and c), compared to the tissue type-specific distribution of epithelial cancer cells (Supplementary Fig. S1d). The normalized proportion of different clusters varied substantially among the different malignant states and cancer types (Fig. 1d and Supplementary Data 3). Although the composition of the five major components was relatively homogenously distributed among normal, adjacent, and tumor tissues, cells from cancer/adjacent tissues were predominantly enriched in specific clusters (e.g., c2 and c9), and vice versa (e.g., c3) (Fig. 1e). Additionally, some clusters, particularly c20 (FABP4+ macrophages), exhibited cancer type enrichment, which was consistent with an independent study on lung cancer26 (Fig. 1f). Intriguingly, a significant stepwise decrease in the proportion of FABP4+ macrophages (c20) but not other macrophage clusters (i.e., IL1B+, SPP1+, and APOE+) was observed along with adjacent controls, early- and late-stage primary